Ignite Creation Date:
2024-05-06 @ 10:37 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03301844
Status:
COMPLETED
Last Update Posted:
2019-12-19
First Post:
2017-08-02
Brief Title:
To Compare Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Bilateral Posterior Blepharitis
Sponsor:
NTC srl
Organization:
NTC srl
Study Overview
Official Title:
Randomized Controlled Study With a Closed Sequential Design to Compare the Efficacy Safety and Patient Satisfaction of Blephapad Combo vs Standard Treatment for Eyelid Cleansing in Patients Affected by Bilateral Posterior Blepharitis
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy of and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis
Detailed Description:
Blepharitis is the most common condition in patients seeking an eye examination due to discomfort or eye irritation Treatment of blepharitis is recommended even in mild cases as chronic inflammation may cause permanent damage to the Meibomian glands
Each eye of each patient represents an experimental unit Each patient will apply Blephapad Combo to one eye and standard treatment to the other eye in accordance with the randomization procedure
The aim of this randomized controlled study with a closed sequential design is to evaluate versus standard treatment the efficacy of and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis
Each eye of each patient represents an experimental unit Each patient will apply Blephapad Combo to one eye and standard treatment to the other eye in accordance with the randomization procedure
The aim of this randomized controlled study with a closed sequential design is to evaluate versus standard treatment the efficacy of and patient satisfaction with Blephapad Combo in the treatment of posterior blepharitis
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None